CD274 and non-small cell lung carcinoma: Instead, integrating together multiple variables, such as PD-L1, TMB, genomic alterations (e.g., KRAS, STK11, and KEAP1 molecular status in the case of NSCLC), and inflammatory markers may result in enhanced predictive accuracy.